Your browser is no longer supported. Please, upgrade your browser.
Settings
XLV Health Care Select Sector SPDR ETF daily Stock Chart
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week2.68%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-7.96%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-5.37%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-1.80%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year11.88%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range56.63 - 77.40 Perf YTD3.73%
Dividend0.90 P/FCF- EPS past 5Y- ROI- 52W High-8.93% Beta-
Dividend %1.28% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low24.47% ATR2.12
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)38.10 Volatility3.08% 2.96%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.68 Prev Close71.80
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.02M Price70.49
Recom- SMA20-4.94% SMA50-6.20% SMA200-2.51% Volume15,124,868 Change-1.82%
Aug-31-15 04:43PM  All 10 S&P 500 sectors decline in August, led by health care at MarketWatch
02:07PM  Market bounces back, still down
08:43AM  Good time to reassess portfolio: Pro
Aug-29-15 12:07AM  AstraZenecas Profitability for 2Q15
Aug-27-15 02:31PM  Cholesterol drug wars
01:56PM  Best way to play the market
10:00AM  Ochsner's Rise After Katrina
09:42AM  Pisani's market open: All 30 Dow stocks higher
Aug-26-15 01:55PM  We are entering a bear market: Pro
Aug-25-15 05:39PM  Worst is over: Tom Lee
04:04PM  Short-Sellers Win Even With One Hand Tied Behind Their Backs at Barrons.com
03:02PM  Consumer names and tech lead the way in market rebound
02:33PM  An Analysis of AstraZenecas Growth Rate
Aug-21-15 07:05AM  Market's big sell-off
Aug-20-15 07:49AM  Stocks sink worldwide; Weather Channel sale?; $1B for 'Female Viagra' maker
Aug-18-15 07:05PM  Pfizers Revised Financial Guidance for 2015
05:58PM  Fast Money Final Trade: Oil, S&P, banks & healthcare
Aug-16-15 08:06AM  Whats in Pfizers Product Pipeline?
Aug-14-15 10:06AM  Pfizers Revenue Falls by 7% in 2Q15
09:55AM  (Podcast) The $700 Million Man Who Lost His Fortune ETFguide
Aug-13-15 06:06PM  Pfizer Products with Negative 2Q15 Growth
06:06PM  What Contributed to Pfizers Growth in 2Q15?
04:50PM  The Spark: FDA approves first 3-D printed drugs
Aug-12-15 05:00PM  Pfizers Improving Growth Rate in 2Q15
04:59PM  Pfizer Stock Rises on Positive 2Q15 Earnings Results
03:52PM  Health care & preferred stocks: Pro
02:05PM  CDC: 7 million fewer Americans say theyre uninsured
11:06AM  Wall Street's China problem; Macy's earnings miss; American Apparel on the ropes
Aug-11-15 04:31PM  What Drove Vertexs Revenue in 2Q15?
11:06AM  Why Did Gilead Sciences Stock Rise?
Aug-09-15 06:53PM  More Negatives than Positives, but
Aug-07-15 02:51PM  Health care REIT plays
12:19PM  To Healthcare, With Leverage
Aug-06-15 03:43PM  Avoid Momentum Stocks, as Volatility Could Pick Up
01:39PM  It's a bull market, just doesn't feel good: Pro
06:45AM  Q2 earnings top expectations: Analyst
Aug-05-15 09:06AM  Risks in the TevaAllergan Deal
09:05AM  Parsing the Cigna-Anthem Material Adverse Effect Clause: Part 3
Aug-04-15 12:07PM  How Can Allergan Benefit from the TevaAllergan Deal?
09:07AM  Teva and Allergan Generics Deal Displays Other Synergies
Aug-03-15 03:05PM  Is the CignaAnthem Merger a Setup?
03:05PM  The Risk-to-Reward Ratio of the CignaAnthem Merger
03:05PM  Teva Can Benefit by Acquiring Allergan Generics
03:01PM  Teva Announces Its Acquisition of Allergan Generics
12:10PM  There's money to be made in energy: Pro
Aug-01-15 07:45AM  Common Missteps With Charts, Rates, and Market Breadth
Jul-31-15 04:24PM  Ebola game changer?
02:11PM  Nervous Nellies to sidelines, please
02:09PM  Bull trades for dog days
02:01PM  Weekend Reads for Global Investors: Bridgewater, the Financial Times, and Gold
09:06AM  Could the CignaAnthem Merger Get Competitive?
07:00AM  Avoiding Medicare mistakes
Jul-30-15 03:42PM  The Cigna-Anthem Merger: Background on Cigna
11:07AM  CignaAnthem Merger: Why Scale Matters to Health Insurers
09:29AM  Reaping the Benefits of an Aging World Market Realist
09:06AM  How the CignaAnthem Merger Will Go Down
09:06AM  Novartiss Shares Fall after 2Q15 Earnings
08:05AM  Earnings halftime scorecard
Jul-29-15 11:06AM  Why Sandoz Revenues Were Important for Novartis in 2Q15
09:58AM  The Huge Spread on the CignaAnthem Merger
09:58AM  Cigna Accepts Anthems Higher Offer
09:06AM  Why Alcons Performance Was Weak in 2Q15
Jul-28-15 11:46AM  Why Novartiss Revenues Declined Marginally
11:45AM  Novartiss Adjusted Earnings per Share Declined 7% in 2Q15
09:06AM  Leading Economic Index Indicates Steady Growth in the US
07:44AM  Dissecting big pharma's numbers: Pro
07:09AM  Buy market dips and focus on growth: Pro
Jul-27-15 09:23AM  Investing With A High Probability Of Global Recession at Forbes
Jul-24-15 03:19PM  Doctors fight to lower cancer drugs cost
07:46AM  3D printing: Revolutizing prosthetics and sports
Jul-22-15 03:06PM  Is UnitedHealth Group a Better Partner for Cigna?
03:06PM  The CignaAnthem Deal: Whats in It for Cigna?
08:44AM  ETF Analysis: Health Care Select Sector SPDR at Investopedia
Jul-21-15 01:26PM  Anthem Should Benefit by Acquiring Cigna
01:24PM  Will Anthem Acquire Cigna?
08:05AM  Parsing the Humana-Aetna MAE Clause
Jul-18-15 09:13AM  The Week Ahead: Damn the Torpedoes .... at Forbes
Jul-17-15 02:20PM  UCLA health system hacked
09:25AM  How Can Changing Demographics Impact Investors?
08:00AM  Shark Tank's Mr. Wonderful has 'sit and wait' stock-picking strategy
Jul-16-15 02:05PM  A Deeper Look into the Humana-Aetna MAE Clause
01:06PM  What Does the Humana-Aetna Material Adverse Effect Clause Say?
07:05AM  How to Trade the Deal between Humana and Aetna
Jul-15-15 04:06PM  What Is the Risk-to-Reward Ratio of the HumanaAetna Deal?
04:06PM  Could Competing Bids Disrupt Aetnas Purchase of Humana?
03:54PM  Health care pick: Becton Dickinson
01:05PM  Some Good Reasons Why Aetna Wants to Consolidate with Humana
12:05PM  The Aetna-Humana Deal: Must-Know Risks to Consider
Jul-14-15 11:56AM  Two Sectors Breaking Out at Forbes
Jul-13-15 04:16PM  What to expect from Johnson & Johnsons earnings at MarketWatch
11:29AM  Why The Next 10% Move In U.S. Stocks Is Higher, Not Lower at Forbes
Jul-12-15 09:05AM  Antitrust Is the Biggest Risk in the HumanaAetna Deal
09:05AM  The Aetna-Humana Deal: Analyzing Market Response
Jul-10-15 06:59PM  Health Care, Financial Stocks Will Have a Better 2Q Earnings Season at TheStreet
04:42PM  New wave of digital health
11:06AM  Aetna Projects Annual Synergies through Its Humana Acquisition
08:45AM  A Live Lesson in Value-Investing: The Energy Meltdown
Jul-09-15 03:20PM  What to Buy in Biotech at Barrons.com
02:56PM  Whats on the Line with Aetnas Proposed Acquisition of Humana?
02:56PM  Humana and Aetna Test the Post-Obamacare Landscape
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.